TNF and neoplasm: Two 4‐wk cycles of QDS intradermal doses of monocyte‐derived dendritic cells preloaded with autologous tumour lysate and matured for 24 h with poly‐ICLC, TNF‐α and IFN‐α on days +8 and + 10 of each cycle, patients received intratumoural 0.25‐mg injections of the dsRNA‐analogue Hiltonol. 6/15 patients received SABR on selected tumour lesions.